A protein may help brain tumors hide from the immune system
Original title: IFI30 reprograms glioblastoma-associated macrophage and induces immune evasion by MAFF/PTGS2 pathway.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in the lab and in animals, not in people.
The short version
Scientists found a protein that seems to help brain tumors block the body's defenses.
What was studied. Researchers looked at a protein called IFI30 in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a fast growing brain tumor. They used computer data, tumor cells in the lab, and tests in animals.
What they found. IFI30 levels were high in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. The protein changed which immune cells moved into the tumor. It also lowered the share of CD8+ T cells, a kind of immune cell that helps fight tumors. The team mapped the steps the protein used to do this.
What this means, and what it doesn't
What it could mean: IFI30 could become a target for future treatments. Blocking it might help the immune system fight the tumor. That idea still has to be tested.
What it doesn't mean: This does not mean there is a new treatment. The work was done in lab dishes, in computer data, and in animals. It was not tested in people. It is not a cure, and it is far from everyday care. Much more testing would come first, and many findings like this never become a drug.
Source: PubMed, June 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.